Thirumalai Chemicals To Weigh Preferential Share Issue In Upcoming Board Meeting

Image Source: Justdial

Thirumalai Chemicals Ltd has announced a board meeting scheduled for October 25, 2025, to consider issuing equity shares on a preferential basis. The move, subject to SEBI and shareholder approvals, could reshape the company’s capital structure and support future growth initiatives across its chemical manufacturing operations.

Board to evaluate equity infusion strategy

Thirumalai Chemicals Ltd (TCL), a leading manufacturer of phthalic anhydride and other industrial chemicals, is set to deliberate on a potential preferential share issue during its upcoming board meeting on October 25, 2025. The company disclosed the agenda in a regulatory filing, stating that the proposal aligns with its capital-raising plans and long-term strategic goals.

The preferential allotment, if approved, will be conducted under SEBI’s Issue of Capital and Disclosure Requirements (ICDR) regulations. It will also require shareholder consent through a special resolution and subsequent regulatory clearances.

Trading window closed ahead of decision

In accordance with SEBI’s insider trading norms, Thirumalai Chemicals has implemented a trading window closure for designated persons from October 1, 2025, until 48 hours after the declaration of Q2 financial results. This ensures transparency and prevents any misuse of unpublished price-sensitive information.

The company has not yet disclosed the quantum of shares to be issued or the pricing details, which are expected to be finalized during the board meeting. Analysts believe the move could be aimed at funding expansion projects, improving working capital, or reducing debt.

Key highlights of the preferential issue proposal

- Thirumalai Chemicals to consider issuing equity shares on a preferential basis
- Board meeting scheduled for October 25, 2025
- Proposal subject to SEBI regulations and shareholder approval
- Trading window closed from October 1 to post-Q2 results declaration
- Pricing and quantum of shares to be determined in the meeting
- Potential use of funds includes expansion, working capital, or debt reduction
- Preferential issue may alter capital structure and promoter holding
- Regulatory filings made in compliance with SEBI LODR norms

Looking ahead

Investors and market participants will closely monitor the outcome of the board meeting, as the preferential issue could signal strategic shifts in Thirumalai Chemicals’ growth trajectory. The company’s ability to attract quality investors and deploy capital effectively will be key to its future performance.

Sources: ScanX News, Rediff MoneyWiz, Thirumalai Chemicals Official Website